Overview of immunosuppression in liver transplantation
Authors:
- Anjana A PillaiAPAnjana A Pillai
- Josh LevitskyJLJosh Levitsky
Open Access
- 1 January 2009
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 15 (34) , 4225-4233
Abstract
Continued advances in surgical techniques and immunosuppressive therapy have allowed liver transplantation to become an extremely successful treatment option for patients with end-stage liver disease. Beginning with the revolutionary discovery of cyclosporine in the 1970s, immunosuppressive regimens have evolved greatly and current statistics confirm one-year graft survival rates in excess of 80%. Immunosuppressive regimens include calcineurin inhibitors, anti-metabolites, mTOR inhibitors, steroids and antibody-based therapies. These agents target different sites in the T cell activation cascade, usually by inhibiting T cell activation or via T cell depletion. They are used as induction therapy in the immediate peri- and post-operative period, as long-term maintenance medications to preserve graft function and as salvage therapy for acute rejection in liver transplant recipients. This review will focus on existing immunosuppressive agents for liver transplantation and consider newer medications on the horizon.Keywords
This publication has 113 references indexed in Scilit:
- Progressive Multifocal Leukoencephalopathy and Use of Mycophenolate Mofetil After Kidney TransplantationTransplantation, 2008
- Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitroBlood, 2008
- Influence of steroids on HCV recurrence after liver transplantation: A prospective studyJournal of Hepatology, 2007
- Operational tolerance in clinical liver transplantation: Emerging developmentsTransplant Immunology, 2006
- The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantationTransplant International, 2006
- Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppressionJournal of Hepatology, 2006
- Promising early results with immunosuppression using rabbit anti-thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipientsLiver Transplantation, 2004
- Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy1Transplantation, 2003
- Orthotopic liver transplantation using low-dose tacrolimus and sirolimusLiver Transplantation, 2001
- Muromonab CD3Drugs, 1996